Pharmacology Department, University of Oxford, OX1 3QT.
Sci Rep. 2011;1:63. doi: 10.1038/srep00063. Epub 2011 Aug 12.
Azoreductases are well known for azo pro-drug activation by gut flora. We show that azoreductases have a wider role in drug metabolism than previously thought as they can also reduce and hence activate nitrofurazone. Nitrofurazone, a nitroaromatic drug, is a broad spectrum antibiotic which has until now been considered as activated in bacteria by nitroreductases. The structure of the azoreductase with nitrofurazone bound was solved at 2.08 Å and shows nitrofurazone in an active conformation. Based on the structural information, the kinetics and stoichiometry of nitrofurazone reduction by azoreductase from P. aeruginosa, we propose a mechanism of activation which accounts for the ability of azoreductases to reduce both azo and nitroaromatic drugs. This mode of activation can explain the cytotoxic side-effects of nitrofurazone through human azoreductase homologues.
还原酶通过肠道菌群对偶氮前药的激活而广为人知。我们发现还原酶在药物代谢中具有比以前认为的更广泛的作用,因为它们还可以还原并因此激活硝呋太尔。硝呋太尔是一种硝基芳烃药物,是一种广谱抗生素,迄今为止被认为是通过硝基还原酶在细菌中被激活的。与硝呋太尔结合的还原酶的结构在 2.08Å 处得到解决,显示硝呋太尔处于活性构象。基于结构信息、铜绿假单胞菌还原酶对硝呋太尔的动力学和化学计量学研究,我们提出了一种激活机制,该机制解释了还原酶还原偶氮和硝基芳烃药物的能力。这种激活模式可以通过人类还原酶同源物来解释硝呋太尔的细胞毒性副作用。